In

Comments
  • tupiela

    Reanalysis of the first case of Alzheimer s disease tamoxifen serm Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL 2 inhibitor venetoclax

Leave a Comment